Download PDF
Thromb Haemost 1975; 33(01): 051-062
DOI: 10.1055/s-0038-1647810
Meeting of the International Committee on Thrombosis and Haemostasis — Symposium on Heparin, Basel, Switzerland, September, 1974
Schattauer GmbH

The Effect of Heparin on Factor XIa and Plasmin[*]

Robert D Rosenberg
1   Departments of Medicine of the Harvard Medical School and the Beth Israel Hospital, Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

 

* Presented at the Symposium on Heparin, Basel, Switzerland, September, 1974.


 

  • References

  • 1 Abildgaard U. Highly purified antithrombin III with heparin cofactor activity prepared by disc electrophoresis. Scandinavian Journal of clinical and Laboratory Investigation 1968; 21: 89.
    CrossrefPubMedGoogle Scholar
  • 2 Amir J, Pensky J, Ratnoff O. D. Plasma inhibition of activated plasma thromboplastin antecedent (factor XIa) in pregnancy. Journal of Laboratory and clinical Medicine 1972; 79: 106.
    PubMedGoogle Scholar
  • 3 Biggs R, Denson K. W. E, Akman N, Borrett R, Hadden M. Antithrombin III, antifactor Xa and heparin. British Journal of Haematology 1970; 19: 293.
    PubMedGoogle Scholar
  • 4 Blombäck B, Blombäck M, Hessel B, Iwanaga S. Structure of N-terminal fragments and specificity of thrombin. Nature 1967; 215: 1445.
    CrossrefPubMedGoogle Scholar
  • 5 Contejean C. Recherches sur les injections intraveineuses de peptone et leur influence sur la coagulabilité du sang chez le chien. Archives de Physiologie normale et de Pathologie 1895; 7: 45.
    PubMedGoogle Scholar
  • 6 Damus P. S, Hicks M, Rosenberg R. D. Heparin – A generalized view of its anticoagulant action. Nature 1973; 246: 355.
    CrossrefPubMedGoogle Scholar
  • 7 Davie E. W, Ratnoff O. D. The proteins of blood coagulation. The Proteins Neurath ed., Academic Press. 1965; 3: 359.
    PubMedGoogle Scholar
  • 8 Deutsch D. G, Mertz E. T. Plasminogen: Purification from human plasma by affinity chromatography. Science 1970; 170: 1095.
    CrossrefPubMedGoogle Scholar
  • 9 Dombrose F. A, Seegers W. H, Sedensky J. A. Antithrombin. Inhibition of thrombin and autoprothrombin C (F–Xa) as a mutual depletion system. Thrombosis et Diathesis haemorrhagica 1971; 26: 103.
    PubMedGoogle Scholar
  • 10 Gladner J. A, Laki K. The active site of thrombin. Journal of the American Chemical Society 1958; 80: 1263.
    CrossrefPubMedGoogle Scholar
  • 11 Highsmith R. F, Rosenberg R. D. The inhibition of human plasmin by human antithrombin-heparin cofactor. Journal of biological Chemistry 1974; 249: 4335.
    PubMedGoogle Scholar
  • 12 Howell W. H. The coagulation of blood. Harvey Lectures 1916; 2: 272.
    PubMedGoogle Scholar
  • 13 Magnusson S. Homologies between thrombin and other serin proteinases. Biochemical Journal 110 1968; 25
    PubMedGoogle Scholar
  • 14 Monkhouse F. C, France E. S, Seegers W. H. Studies on antithrombin and heparin cofactor activities of a fraction adsorbed from plasma by aluminum hydroxyde. Circulation Research 1955; 3: 397.
    CrossrefPubMedGoogle Scholar
  • 15 Morowitz R. The Chemistry of Blood Coagulation. Charles C. Thomas, Springfield; Illinois.: 1968
    Google Scholar
  • 16 Nemerson Y, Esnouf M. P. Activation of a proteolytic system by a membrane lipoprotein: mechanism of action of tissue factor. Proceedings of the National Academy of Sciences 1973; 70: 310.
    CrossrefPubMedGoogle Scholar
  • 17 Nossel H. L. The Contact Phase of Blood Coagulation. Blackwell: Oxford.; 1964
    Google Scholar
  • 18 Rapaport S. I, Schiffman S, Patch M. J, Ware A. G. A simple specific one-stage assay for plasma thromboplastin antecedent activity. Journal of Laboratory and clinical Medicine 1961; 57: 771.
    PubMedGoogle Scholar
  • 19 Rosenberg R. D, Damus P. S. The purification and mechanism of action of human antithrombin-heparin cofactor. Journal of biological Chemistry 1973; 248: 6490.
    PubMedGoogle Scholar
  • 20 Seegers W. H, Cole E. R, Harmison C. R, Monkhouse F. C. Neutralization of autoprothrombin C activity with antithrombin. Canadian Journal of Biochemistry 1964; 42: 359.
    CrossrefPubMedGoogle Scholar
  • 21 Summaria L, Hsieh B, Groskopf W. R, Robbins K. C, Barlow G. H. The isolation and characterization of the S-carboxymethyl beta (light) chain derivative of human plasmin. The localization of the active site on the beta (light) chain. Journal of biological Chemistry 1967; 242: 5046.
    PubMedGoogle Scholar
  • 22 Wuepper K. D, Cochrane C. G. Plasma prekallikrein : isolation, characterization, and mechanism of activation. Journal of experimental Medicine 1972; 135: 1.
    CrossrefPubMedGoogle Scholar
  • 23 Yin E. T, Wessler S, Stoll P. J. Rabbit plasma inhibitor of the activated species of blood coagulation factor X: purification and some properties. Journal of biological Chemistry 1971; 246: 3694.
    PubMedGoogle Scholar